Xarano intracameral ethacrynate sodium data

TELR (Wilmington, Mass.) presented Phase I/II results suggesting efficacy and showing no adverse effects.

As reported at the meeting of the Association for Ocular Pharmacology and Therapeutics in New Orleans, evidence was found for a drug effect in the 24-hour post-operative period, although the 12 patients enrolled were not sufficient to show statistical significance. ...